Author/Editor | Jevšnik Virant, Monika; Uršič, Tina; Kogoj, Rok; Korva, Miša; Petrovec, Miroslav; Avšič-Županc, Tatjana | |
Title | Evaluation of two broadly used commercial methods for detection of respiratory viruses with a recently added new target for detection of SARS-CoV-2 | |
Type | članek | |
Vol. and No. | Letnik 14, št. 7 | |
Publication year | 2022 | |
Volume | str. 1-10 | |
ISSN | 1999-4915 - Viruses | |
Language | eng | |
Abstract | The clinical symptoms caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are nonspecific and can be associated with most other respiratory viruses that cause acute respiratory tract infections (ARI). Because the clinical differentiation of COVID-19 patients from those with other respiratory viruses is difficult, the evaluation of automated methods to detect important respiratory viruses together with SARS-CoV-2 seems necessary. Therefore, this study compares two molecular assays for the detection of respiratory viruses, including SARS-CoV-2: the Respiratory Viruses 16-Well Assay (AusDiagnostics, Pty Ltd., Mascot, Australia) and the Allplex™ RV Essential Assay coupled with the Allplex™-nCoV Assay (Seegene Inc., Seoul, Korea). The two methods (AusDiagnostics and AlplexTM-nCoV Assay SARS-CoV-2) had 98.6% agreement with the reference method, cobas 6800, for the detection of SARS-CoV-2. Agreement between the AusDiagnostics assay and the AlplexTM RV Essential Assay for the detection of seven respiratory viruses was 99%. In our experience, the Respiratory Viruses 16-Well Assay proved to be the most valuable and useful medium-throughput method for simultaneous detection of important respiratory viruses and SARS-CoV-2. The main advantages of the method are high specificity for all targets included and their simultaneous detection and medium throughput with the option of having multiple instruments provide a constant run. | |
Keywords | respiratory viruses validation molecular assay respiratorni virusi validacija molekularni test |